CORAL GABLES, FL / ACCESSWIRE / February 27, 2019 / The marijuana stock market has come quite a long way over the course of the past few years. Generations upon generations have disregarded cannabis and its associated companies because the federal government held it to the same status as meth and LSD. However, following the advent of legislation in support of cannabis legalization, society has had a massive change of heart. For the future of the cannabis industry to be secured, companies in the space need to continue to create innovative products that will ultimately improve the quality of life for consumers. Premier Health Group (OTC:PHGRF) (CSE:PHGI), MedMen Enterprises Inc (MMNFF) (CSE:MMEN), Charlotte's Web Holdings Inc (CWBHF), and Insys Thereapeutics Inc (INSY) represent 4 marijuana stocks that are heating up on Wednesday.
Premier Health Group (OTC:PHGRF) (CSE:PHGI) is a company keenly focused on developing innovative approaches that combine human skill-based expertise with state-of-the-art technologies to offer the best quality treatments for its patients.
Premier Health Group (OTC:PHGRF) (CSE:PHGI) yesterday announced plans to expand its development team at Cloud Practice Inc. to support the Company's focus on digitizing health care. The Company recently hired four new full-time employees, three Web Software Developers and one User Interface/User Experience (UI/UX) Designer, to support the build-out of its patient-centric platform and mobile app - a beta version of which will be available by end of Q2.
Following the announcement, Dr. Essam Hamza, CEO of Premier Health Group (OTC:PHGRF) (CSE:PHGI), commented, The future of healthcare is digitally driven and this strategic investment in growing Cloud Practice's team will enable us to fast-track the build out our app - a much-needed technology innovation in healthcare. Our goal is to tackle the accessibility bottlenecks by putting the power in the hands of patients. Not only will our app enable patients' access to their health care providers, but also allow for cohesive patient care by coordinating and connecting all members of their health care team.''
For More Information On Premier Health Group, Click Here
MedMen Enterprises Inc ( MMNFF ) (MMEN) announced earlier this month that the Company had closed its previously announced acquisition of Kannaboost Technology Inc. and CSI Solutions LLC, collectively referred to as ''Level Up,'' two vertically-integrated operations in Arizona. The acquisition includes retail locations in Scottsdale and Tempe, as well as 25,000 square feet of cultivation and production capacity in Tempe and Phoenix.
Per the details of the agreement, the acquisition also includes a 40 percent stake in top-selling brand K.I.N.D. Concentrates, which is currently distributed in over 90 percent of the dispensaries in Arizona. The Company paid a combination of cash and stock valued at an aggregate of $33.5 million.
For More Information on MedMen Enterprises Inc, Click Here
Charlotte's Web Holdings Inc (CWBHF) announced towards the tail-end of January that Stephen Lermer had joined the Company in the newly formed role of Chief Operating Officer effective January 28, 2019.
At the time of the announcement, Hess Moallem, President and CEO of Charlotte's Web, said, ''his appointment dramatically expands our domestic and international operational capabilities and brings high-level pharmaceutical quality and operating expertise to our organization. I've had the privilege of working with Stephen in the past and consider him a trusted advisor.''
For More Information On Charlotte's Web Holdings Inc, Click Here
Insys Therapeutics Inc (INSY) enjoyed impressive gains during early afternoon trading on Wednesday, with its shares up 2.33%, trading at $6.15 per share. The Company announced earlier this week that it had presented results for its initial pharmacokinetic (PK) study of comparative bioavailability of epinephrine nasal spray and EpiPen® in adults with seasonal allergies at the American Academy of Allergy, Asthma and Immunology Annual Meeting in San Francisco, California on Feb. 24, 2019.
Dr. Venkat Goskonda, Senior Vice President of Research and Development at Insys, stated, ''these results presented to the scientific community further support the potential for a needle-less alternative to the current standard of care and further validates the viability of an intranasal delivery system for epinephrine for the treatment of allergic reactions including anaphylaxis.''
For More Information On Insys Therapeutics Inc, Click Here
What Is Stock Price (StockPrice.com)?
Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for.
StockPrice.com was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.
At Stock Price (StockPrice.com), you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns www.StockPrice.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
JSG Communications, LLC, which owns www.StockPrice.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns www.StockPrice.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 - 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 ( CASH) for & were paid ''500,000'' shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the ''500,000'' shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.
Contact Information:
SOURCE: StockPrice.com
View source version on accesswire.com:
https://www.accesswire.com/537344/Four-Marijuana-Stocks-Seeing-New-Highs-On-Wednesday